Immunohistochemistry of participants A’s colon cancer biopsy demonstrated loss of protein expression of MLH1 and PMS2, indicative of MLH1 loss of function, and no BRAF V600 mutation was found in tumour DNA. The gene discussed is PMS2; the disease is malignant colon neoplasm.